Navigation For Mobile
  1. >
  2. Author: Saharsh Davuluri

Author Archives: Saharsh Davuluri

Putting Customers First: Customer Centricity in Pharma API Manufacturing

Customer centricity is central to every organization and an important strategic priority for B2B companies. While there are many definitions of customer centricity, the ultimate objective of a customer-centric organization…

Posted in APIs, Neuland Labs | Tagged , , | Comments Off on Putting Customers First: Customer Centricity in Pharma API Manufacturing

Planning for An Unpredictable 2023: Effective Pharma Risk Management Strategies

Congratulations! The last three years have been a Ph.D. in Supply Chain Disaster Management for Supply Chain teams! It’s undeniable that the last few years have highlighted a variety of…

Posted in Neuland Labs, Quality, regulatory, supply chain | Tagged , , | Comments Off on Planning for An Unpredictable 2023: Effective Pharma Risk Management Strategies

End-to-End Focus on Quality in API Manufacturing

The past few years have seen major changes to the ways in which drug companies and their regulators go about ensuring the safety and efficacy of drugs. The response to…

Posted in APIs, Quality | Tagged , , , , | Comments Off on End-to-End Focus on Quality in API Manufacturing

Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing

Digital transformation went from a popular corporate buzz phrase to an essential survival tool with the outbreak of the COVID-19 pandemic. Industries ranging from banking and restaurants to travel and…

Posted in Capabilities, Contract Manufacturing, data, Neuland Labs | Tagged , , , | Comments Off on Ensuring Rock-Solid IT Infrastructure in Contract Manufacturing

3 Key Elements of a Successful Hydrogenation Scale-Up

Pharmaceutical process chemistry has come a long way since wholesale merchants began the commercial marketing of drugs in the 19th century. In fact, process chemistry has driven many of the…

Posted in API synthesis, APIs, Capabilities, Chemistry | Tagged , | Comments Off on 3 Key Elements of a Successful Hydrogenation Scale-Up

Pharma Industry Zeroes in on Drug Manufacturing Sustainability

Sustainability has become a key trend in drug manufacturing. As we’ve previously discussed (here and here), this is being driven by environmental/good corporate stewardship efforts as well as various cost…

Posted in EHS, green chemistry, zero liquid discharge | Tagged , , | Comments Off on Pharma Industry Zeroes in on Drug Manufacturing Sustainability

A Novel Method of Manufacturing Alcaftadine

Conjunctivitis (known as ‘pink eye’) is the infection or inflammation of the conjunctiva—the mucous membrane that covers the eye’s outer surface. In the United States, this uncomfortable ophthalmic condition affects…

Posted in API synthesis, APIs, Chemistry, Contract Manufacturing, generic | Tagged , , , | Comments Off on A Novel Method of Manufacturing Alcaftadine

Why is Pharmaceutical Green Chemistry Use on the Rise?

Green chemistry principles first emerged in the 1990s, and the pharmaceutical industry – especially larger, global organizations – began steadily incorporating its principles in subsequent years. Here are some recent…

Posted in Chemistry, Effluent, EHS, energy conservation, energy effciency, green chemistry | Tagged , , | Comments Off on Why is Pharmaceutical Green Chemistry Use on the Rise?

Selecting Regulatory Starting Materials: A Q&A With Neuland’s Senior VP of Supply Chain Management

As a follow-up to our recent two-part series on Regulatory Starting Materials Sourcing & Supplier Management, we sat down with Senior Vice President of Supply Chain Management at Neuland Labs…

Posted in APIs, CMC, Neuland Labs, supply chain | Tagged , , , | Comments Off on Selecting Regulatory Starting Materials: A Q&A With Neuland’s Senior VP of Supply Chain Management

Regulatory Starting Materials: How to Source, Analyze and Validate Suppliers (Part II)

In Part I of this two-part series, we explored sourcing and supplier management of Regulatory Starting Materials (RSMs), and how effective designation and justification of RSMs begins with supplier market…

Posted in API synthesis, APIs, supply chain | Tagged , , , | Comments Off on Regulatory Starting Materials: How to Source, Analyze and Validate Suppliers (Part II)